Table 1. Characteristics and composition of subsets included in the GSEA analysis.
| GEO Accesion | GSE10072 | GSE32863 | TCGA | GSE50081 | GSE47115 | GSE7670 | |||
|---|---|---|---|---|---|---|---|---|---|
| Array | Affymetrix Human Genome U133A | Illumina HumanWG-6 v3.0 | IlluminaHiSeq_RNASeqV2 | Affymetrix Human Genome U133 Plus 2.0 | Illumina HumanHT-12 WG-DASL V4.0 R2 | Affymetrix Human Genome U133A | |||
| Histology | Adenocarcinoma | Adenocarcinoma | Adenocarcinoma | NSCLC | NSCLC | Adenocarcinoma | |||
| Stage | IA–IV | IA–IV | IA–IIB | IB–IIB | |||||
| Samples evaluated | n = 71 | 116 | 447 | 81 | 16 | 52 | |||
| Subsets in dataset | - | 4 | 4 | 2 | 2 | 1 | 2 | ||
| Never Smokers | Normal Tissue | 31 (43.7%) | 15 (48.4%) | 59 (50.1%) | 30 (50.8%) | ||||
| Male Female |
4 (26.7%) 11 (73.3%) |
7 (23.3%) 23 (76.7%) |
|||||||
| Tumoral Tissue | 16 (51.6%) | 29 (49.2%) | 69 (15.4%) | 24 (29.6%) | |||||
| Male Female |
13 (81.2%) 3 (18.8%) |
6 (20.7%) 23 (79.3%) |
17 (24.6%) 52 (75.4%) |
6 (25%) 18 (75%) |
|||||
| Current Smokers | Normal Tissue | 40 (56.3%) | 16 (40%) | 57 (49.9%) | 28 (49.1%) | ||||
| Male Female |
4 (25%) 12 (75%) |
6 (21.4%) 22 (78.6%) |
|||||||
| Tumoral Tissue | 24 (60%) | 29 (50.1%) | 378 (84.6%) | 57 (70.4%) | 16 (100%) | ||||
| Male Female |
16 (66.7%) 8 (33.3%) |
7 (24.1%) 22 (75.9%) |
187 (49.5%) 191(50.5%) |
36 (63.2%) 21(36.8%) |
9 (56.2%) 7 (43.8%) |
||||
| Unknown | Normal Tissue | 26 (50%) | |||||||
| Male Female |
5 (19.2%) 21 (80.8%) |
||||||||
| Tumoral Tissue | 26 (50%) | ||||||||
| Male Female |
5 (19.2%) 21 (80.8%) |
||||||||